在聚乙二醇干扰素α-2a基础上加用拉米夫定能否维持HBeAg阴性乙型肝炎的应答率？ - Suppr

Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?

作者信息

Cooksley Graham

机构信息

University of Queensland, Royal Brisbane Hospital, Brisbane, Australia.

出版信息

Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):12-3. doi: 10.1038/ncpgasthep0068.

DOI:10.1038/ncpgasthep0068

PMID:16265091

Abstract

摘要

相似文献

Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?

Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):12-3. doi: 10.1038/ncpgasthep0068.

[Interferon therapy for chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):726-9.

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

N Engl J Med. 2004 Sep 16;351(12):1206-17. doi: 10.1056/NEJMoa040431.

Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.

J Dig Dis. 2013 Aug;14(8):446-50. doi: 10.1111/1751-2980.12065.

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

N Engl J Med. 2005 Jun 30;352(26):2682-95. doi: 10.1056/NEJMoa043470.

Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.

Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1165-9. doi: 10.1097/MEG.0b013e3283612e95.

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

Gut. 2007 May;56(5):699-705. doi: 10.1136/gut.2005.089722. Epub 2006 Nov 24.

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.

Hepatology. 2005 Jun;41(6):1357-64. doi: 10.1002/hep.20695.

A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.

Am J Gastroenterol. 2007 Dec;102(12):2718-23. doi: 10.1111/j.1572-0241.2007.01449.x. Epub 2007 Jul 27.

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?

作者信息

机构信息

出版信息

相似文献